From: Sputum mediator profiling and relationship to airway wall geometry imaging in severe asthma
Mediators included in analysis | Not measurable in >50Â % of samples, excluded |
---|---|
Factor VII | Brain-Derived Neurotrophic Factor (BDNF) |
Fibrinogen | C-Reactive Protein (CRP) |
Ferritin (FRTN) | Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) |
Intercellular Adhesion Molecule 1 (ICAM-1) | Interferon gamma (IFN-gamma) |
Interleukin-1 alpha (IL-1 alpha) | Interleukin-17 (IL-17) |
Interleukin-1 beta (IL-1 beta) | Interleukin-2 (IL-2) |
Interleukin-1 receptor antagonist (IL-1ra) | Interleukin-3 (IL-3) |
Interleukin-6 (IL-6) | Interleukin-4 (IL-4) |
Interleukin-8 (IL-8) | Interleukin-5 (IL-5) |
Interleukin-15 (IL-15) | Interleukin-7 (IL-7) |
Interleukin-18 (IL-18) | Interleukin-10 (IL-10) |
Monocyte Chemotactic Protein 1 (CCL2) | Interleukin-12 Subunit p70 (IL-12p70) |
Macrophage Inflammatory Protein-1 beta (CCL4) | Interleukin-12 Subunit p40 (IL-12p40) |
Eotaxin-1 (CCL11) | Interleukin-23 (IL-23) |
Matrix Metalloproteinase-3 (MMP-3) | Macrophage Inflammatory Protein-1 alpha (CCL-3) |
Matrix Metalloproteinase-9 (MMP-9) | Matrix Metalloproteinase-2 (MMP-2) |
Tissue Inhibitor of Metalloproteinase 1 (TIMP-1) | Stem Cell Factor (SCF) |
Tumor Necrosis Factor alpha (TNF-alpha) | T-Cell-Specific Protein (CCL-5) |
Tumor Necrosis Factor Receptor 2 (TNFR2) | Tumor Necrosis Factor β (TNF-β) |
Vascular Cell Adhesion Molecule-1 (VCAM-1) | von Willebrand Factor (vWF) |
Vascular Endothelial Growth Factor (VEGF) | Â |